- Home
- THW vs ORGO Comparison
THW vs ORGO Comparison
Compare THW & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THW | ORGO |
|---|---|---|
| Founded | N/A | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.9M | 514.0M |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | THW | ORGO |
|---|---|---|
| Price | $12.06 | $2.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 139.8K | ★ 661.5K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.84 |
| P/E Ratio | ★ N/A | $19.37 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $9.80 | $2.61 |
| 52 Week High | $13.19 | $7.08 |
Technical Indicators
Market Signals| Indicator | THW | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 24.47 |
| Support Level | $11.80 | $2.61 |
| Resistance Level | $12.13 | $3.28 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 13.50 | 2.00 |
Price Performance
Historical ComparisonAbout THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.